Physician

Christopher E Howson, M.D.

According to 2025 Medicare claims, Christopher Howson, M.D. (NPI: 1508129826) practices pain management in the Green Bay, WI market, with the plurality of this provider's patient population coming from Brown, WI. This provider's primary affiliated billing organization is BAYCARE CLINIC LLP (NPI: 1588609648; TIN: 391943214) and primary practice location at 54311-6519. Howson is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033), OSF Healthcare System (ACO ID: A3289), and THEDACARE ACO (ACO ID: A4988), participating under the MSSP model.

Howson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 365 traditional Medicare patients, billed 4,143 HCPCS/CPT codes, and received $135,784 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,224 prescription claims across 554 beneficiaries totaling $84,585 in drug costs, led by Belbuca (Buprenorphine Hcl). Open Payments data shows 52 records totaling $15,210. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $42,210 to $135,784. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $16,441 and ending at $84,585. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	121	562	$42,210
2018	267	1,730	$98,625
2019	329	2,460	$125,306
2020	329	3,010	$118,305
2021	377	3,569	$158,125
2022	390	3,579	$128,269
2023	380	4,263	$145,294
2024	365	4,143	$135,784

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	118	359	$16,441
2018	335	1,673	$109,324
2019	408	1,947	$91,750
2020	350	1,319	$41,146
2021	440	1,452	$43,268
2022	481	1,818	$49,443
2023	503	1,819	$60,480
2024	554	2,224	$84,585

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	103	103	$105
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	63	68	$87
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	174	323	$86
27096	Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance	59	84	$67
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	61	75	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Belbuca	Buprenorphine Hcl	13	390	$10,405
Gabapentin	Gabapentin	376	16,219	$6,874
Buprenorphine	Buprenorphine	35	959	$6,647
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	302	7,076	$5,595
Xtampza Er	Oxycodone Myristate	13	344	$5,473

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	52	$15,210	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher E. Howson, M.D.?

Tedicare shows public-source Medicare data for Christopher E. Howson, M.D. (NPI 1508129826), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher E. Howson, M.D. have ACO affiliation data?

Christopher E. Howson, M.D. is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033), OSF Healthcare System (MSSP, ACO ID A3289), and THEDACARE ACO (MSSP, ACO ID A4988).

What billing organization is linked to Christopher E. Howson, M.D.?

Christopher E. Howson, M.D. is linked to BAYCARE CLINIC LLP (billing NPI 1588609648) in the available physician profile data.

Does Christopher E. Howson, M.D. have Open Payments data?

Christopher E. Howson, M.D. has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.